Improving care for critically ill children
Collaborative Pediatric Critical Care Research Network - Clinical Site
This effort brings together many children's hospitals to find better ways to treat serious infections and organ problems in very sick children.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Utah State Higher Education System--University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-11170718 on NIH RePORTER |
What this research studies
This initiative is expanding a group of children's hospitals working together to improve care for critically ill children. They are launching a new clinical trial focused on personalized treatments for children with severe infections that cause organ damage. By growing this network, more children across the country will have access to advanced care and cutting-edge research. The goal is to discover more effective ways to help young patients recover from life-threatening conditions.
Who could benefit from this research
Good fit: Children aged 0-11 years old who are critically ill with severe infections (sepsis) and multiple organ problems might be candidates for future participation.
Not a fit: Children who are not critically ill or do not have sepsis-induced multiple organ dysfunction would not directly benefit from this specific treatment approach.
Why it matters
Potential benefit: If successful, this personalized approach could lead to more effective treatments for children suffering from severe infections and organ failure, improving their chances of recovery.
How similar studies have performed: While the network has a strong history of successful multi-center trials, this specific personalized immunomodulation approach for sepsis is a new interventional trial.
Where this research is happening
Salt Lake City, United States
- Utah State Higher Education System--University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Akcan Arikan, Ayse — Utah State Higher Education System--University of Utah
- Study coordinator: Akcan Arikan, Ayse
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.